Background

Background

Follicum is developing drugs based on proteins found naturally in the body of both men and women. The founders discovered that modifications to these proteins had the potential to control the activity of hair follicles. In extensive preclinical efficacy studies Follicum’s drug candidates have clearly shown that they have the potential to both stimulate and inhibit hair growth, the particular effect being depending on the specific treatment model used.

The founders

Follicum’s founders, Anna Hultgårdh Nilsson and Pontus Dunér, both hold a PhD and have published nearly 50 peer reviewed scientific papers between them.